Navigation Links
Tissue Genesis Begins FDA-Approved Clinical Trial
Date:4/19/2011

HONOLULU, April 19, 2011 /PRNewswire/ -- Tissue Genesis, Inc., an emerging leader in adult stem cell and regenerative medicine, announced today that it has begun clinical trials for peripheral vascular disease (PVD) with adipose (fat) derived adult stem cell-coated vascular grafts at the University of Louisville Hospital.  Tissue Genesis is the first to initiate a FDA-approved trial using the patient's own adipose-derived adult stem cells (ASCs) prepared at the point-of-care.  The clinical trial commenced enrollment in April and is led by Dr. Charles B. Ross, a board-certified vascular surgeon and Chief of the Division of Vascular Surgery and Endovascular Therapeutics at the University of Louisville Hospital.

Peripheral vascular disease affects over eight million people in the United States.  By 2020, the number is expected to increase by 43 percent.  PVD includes damage to or blockage in the blood vessels of the peripheral arteries and veins, causing pain and weakness.  Approximately 25 percent of patients progress to critical limb ischemia (CLI), oftentimes leading to amputation In the United States, 130,000 amputations are performed annually due to PVD.

Researchers have been actively seeking a way to coat the inside of synthetic grafts used to treat PVD so that they more closely resemble native vessels and increase long-term graft survival.  The stromal vascular fraction of adipose tissue contains millions of regenerative cells, which can be used to coat the inner surface of vascular grafts.  "Based on previous studies, the potential of ASCs to increase the patency and life of the graft is tremendous," states Dr. Stuart Williams, Chief Science Officer for Tissue Genesis and Executive and Scientific Director of the Cardiovascular Innovation Institute in Louisville, Kentucky.

ASCs are being increasingly looked to as a readily available source abundant in adult stem cells.  Compared to bone marrow de
'/>"/>

SOURCE Tissue Genesis, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. SpectraScience Awarded Patent for Its Optical Biopsy System and Methods for Tissue Diagnosis
2. CSMG Technologies Announces Key Fifth U.S. Tissue Bonding/Welding Patent Approved
3. Global Med Technologies(R), Inc. Partners With Biomedical Synergies to Offer Advanced Tissue Tracking Solutions for Hospitals and Surgery Centers
4. BioLife Solutions Submits FDA Master File on HypoThermosol(R) Preservation and Storage Media for Cells, Tissues
5. Cell/Tissue Culture Supplies Market to Reach $4.97 Billion by 2012, According to New Report by Global Industry Analysts
6. Cardiums InnerCool Announces New Tissue-Specific UroCool(TM) System for Use in Prostate Surgeries
7. Tissue Genesis Applies CE Mark to Its Adult Stem Cell Isolation System
8. Dont Wait - Do It Now!(TM) Become an Organ and Tissue Donor
9. Cardiums InnerCool Announces First Patient Treated With New Tissue-Specific UroCool(TM) System in Robotic-Assisted Prostate Surgery Study
10. AlloSource, Tissue Recipient Join Stars of Life Affected by Organ and Tissue Donation Aboard Donate Life Float in 2009 Rose Parade(R)
11. Bionovo Publishes Discoveries in Predictable Tissue Selectivity for Selective Estrogen Receptor Modulators Platform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/30/2015)... 01, 2015 Spirax Sarco, the leader ... proud to announce that for the first time in ... winner of a Queen’s Award for Innovation – the ... and manufacture of a unique flowmeter. , The Spirax ... to traditional steam flow measurement. The device provides ...
(Date:4/30/2015)... 2015 Nitto Avecia, a leading ... increased capacity and production capability to serve biotechnology ... and service fulfillment continues to drive Nitto Avecia ... throughput capacities. , In Fall 2014, ... process equipment at its Milford, MA facility, which ...
(Date:4/30/2015)... , April 30, 2015  Pfenex Inc. ... in the development of biosimilar therapeutics including high ... the closing of its previously announced underwritten public ... at a public offering price of $15.50 per ... the underwriters of their option to purchase up ...
(Date:4/30/2015)... April 30, 2015 Available in ... http://www.lespausa.com , Phytomer’s DOUCEUR INTEMPORELLE Restorative ... reactive skin while battling the weakening threat of ... cream is formulated with star ingredient GLYCOSEA, a ... in a complex of soothing minerals and trace ...
Breaking Biology Technology:Spirax Sarco Receives a Queen’s Award for Innovation 2Spirax Sarco Receives a Queen’s Award for Innovation 3Biotechnology Manufacturer Nitto Avecia Expands Capacity to Meet Client Demand 2Pfenex Inc. Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares 2Phytomer introduces DOUCEUR INTEMPORELLE Restorative Shield Cream 2Phytomer introduces DOUCEUR INTEMPORELLE Restorative Shield Cream 3
... 2012  Watson Pharmaceuticals, Inc. (NYSE: WPI ), ... Paul Bisaro, Watson,s President and Chief Executive Officer, will ... at the Goldman Sachs Global Healthcare Conference 2012 on ... the Terranea Resort in Rancho Palos Verdes, California.  The ...
... 2012 TOKU-E Company ( http://www.toku-e.com ) ... faster dissolving dust-free grade (DF) Sodium Dodecyl Sulfate (SDS). ... dust particles is known to cause eye and skin ... chronic skin hypersensitivity, with some people being affected more ...
... SEATTLE, May 29, 2012 Cell Therapeutics, Inc. ("CTI") (Nasdaq ... an agreement to sell, subject to customary closing conditions, $40 ... and warrants to purchase shares of its common stock (and ... upon conversion of the Series 15 Convertible Preferred Stock and ...
Cached Biology Technology:Watson to Present at Goldman Sachs Global Healthcare Conference 2012 2TOKU-E Announces Safer and Faster Dissolving, Dust-Free Grade Sodium Dodecyl Sulfate (SDS) for Electrophoresis and Manufacturing Applications 2Cell Therapeutics Announces Institutional Investor to Purchase $40 Million of Convertible Preferred Stock and Warrants to Purchase Common Stock 2Cell Therapeutics Announces Institutional Investor to Purchase $40 Million of Convertible Preferred Stock and Warrants to Purchase Common Stock 3Cell Therapeutics Announces Institutional Investor to Purchase $40 Million of Convertible Preferred Stock and Warrants to Purchase Common Stock 4Cell Therapeutics Announces Institutional Investor to Purchase $40 Million of Convertible Preferred Stock and Warrants to Purchase Common Stock 5Cell Therapeutics Announces Institutional Investor to Purchase $40 Million of Convertible Preferred Stock and Warrants to Purchase Common Stock 6
(Date:3/20/2015)... , Mar. 20, 2015 Research and ... the addition of the "India Sensors Market ... offering. The sensor market is projected ... 2020 Consumer electronics, automotive, industrial and ... sensors in the country. In addition, adoption of ...
(Date:3/20/2015)... Conn. , March 20, 2015 NXT-ID, ... a biometric authentication company focused on the growing mobile ... smart wallet is one of the products featured in ... March 20th at 11:00 PM EST on the DIY ... to Las Vegas , site of ...
(Date:3/19/2015)... Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company"), ... market, announces its biometric payment technology, the Wocket® smart wallet ... on Washington DC,s Fox 5 News ... Next Great Thing", host Laura Evans calls the ... really big breakthrough in mobile payment.,  Award-winning ...
Breaking Biology News(10 mins):India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 2India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 3NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 2NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 3NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 2NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 3
... fictitious storybook character Dr. Doolittle was known for ... professor of psychology at Rochester Institute of Technology, ... object discrimination in goldfish and echolocation in dolphins ... of animal perception and cognition. DeLong,s theories ...
... California, Davis, and BGI, the world,s largest genomic institute, ... will change the landscape of genomic sciences in California ... the areas of food security and human, animal and ... BGI sequencing facility for immediate use on the UC ...
... CAMDEN -- In this era of environmental consciousness, many ... is taking the term quite literally. Elizabeth Demaray, an ... sides of New York City skyscrapers to counteract the lack ... Skyscrapers Project" was featured as part of New York,s Art ...
Cached Biology News:Go fish! RIT psychology professor trains goldfish for object perception research 2UC Davis and BGI announce partnership to establish state-of-the-art genome center in Sacramento 2UC Davis and BGI announce partnership to establish state-of-the-art genome center in Sacramento 3Rutgers professor uses lichen to help cities go green 2Rutgers professor uses lichen to help cities go green 3
BD BioCoat Fibronectin 35 mm Culture Dishes, tissue-culture treated polystyrene with a uniform application of human fibronectin....
... TYPE II Reacts with most of ... cell keratin of 86 and 58kD and ... keratin reactivity is found on human epidermal ... Immunogen: Human epidermal cells ...
BD BioCoat Fibronectin 150 mm Culture Dishes...
... CLS number is a new product number, ... If showing no availability yet, please order ... contact customer service for assistance. ... Dim: surface area 500 cm 2 ...
Biology Products: